Temporary Trial or Direct Implant? Comparing Approaches to Peripheral Nerve Stimulation

Temporary Trial or Direct Implant? Comparing Approaches to Peripheral Nerve Stimulation

By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine

Published October 21, 2025 | Category: Pain Medicine

Before a permanent spinal cord stimulator is implanted, a trial is standard. For peripheral nerve stimulation (PNS), practice varies: some physicians use a temporary PNS trial first, while others implant a permanent device directly. Each additional procedure carries its own risks. A 2025 study in Regional Anesthesia & Pain Medicine compared the two approaches.

This summary is based on the published abstract. Read the abstract on PubMed

What the authors did

At seven academic institutions, the authors reviewed adults who received permanent PNS for chronic pain from 2014 to 2024. They compared patients who had a temporary PNS first (54 patients) with those who went directly to a permanent implant (76 patients), looking at pain relief, opioid use and adverse events at 6 months.

What they found

  • Pain relief at 6 months was 56.7% with a temporary trial and 45.1% with direct implant, a difference that was not statistically significant.
  • Opioid use declined similarly in both groups.
  • Device explant rates and adverse event profiles were comparable.

The authors found no evidence that a temporary trial led to better pain outcomes, and both groups achieved meaningful relief.

Why this matters

Avoiding unnecessary procedures can reduce exposure to infection and other risks, as well as cost. However, a trial may still help some patients decide whether they want a permanent device.

Limitations

This was a retrospective study with a modest sample size, and patients were not randomly assigned. The choice of approach may have reflected patient or physician factors.

Safety takeaways: how to apply it

For pain physicians and procedure teams

  • Individualize the decision about a temporary PNS trial, and document the reasoning.
  • Discuss the risks of each procedure, including infection, lead migration and explant.
  • Track outcomes and complications for both approaches in your practice.

For hospitals, clinics and safety leaders

  • Monitor device explant and complication rates by implant pathway.

For patients and families

  • Ask whether a trial is recommended for you and what the risks and benefits are of each approach.

Reference

  1. D'Souza RS, Yu Y, Singh V, Karri J, Javed S, Her YF, et al. To trial or not to trial before peripheral nerve stimulation for chronic pain: a retrospective multicenter comparative analysis of temporary-to-permanent and direct-to-permanent implantation approaches. Reg Anesth Pain Med. Published online 2025 Jul 13. doi:10.1136/rapm-2025-106734. PMID: 40659443. PubMed: https://pubmed.ncbi.nlm.nih.gov/40659443/

This article is educational information, not legal or medical advice.

Previous
Previous

Preventing Pocket Fills During Intrathecal Pump Refills

Next
Next

Non-Invasive Focused Ultrasound for Lumbar Facet Pain: Early Safety Results